Business & Industry
Boehringer’s Survodutide Cuts Visceral and Liver Fat While Preserving Lean Mass in Late-Stage Trial
German pharmaceutical company Boehringer Ingelheim has reported that its experimental obesity drug, survodutide, significantly reduced visceral abdominal fat and liver fat while largely preserving lean body mass in a late-stage clinical study. The data strengthens the company's argument that...
News
Living with CLL: Understanding Targeted Therapy for CLL and Its Impact
Introduction
Chronic Lymphocytic Leukemia (CLL) is the most common blood cancer in adults. It develops when there is an accumulation of atypical lymphocytes, which are a type of white blood cell in the blood, bone marrow, and lymphatic tissue. Although...
Business & Industry
CytomX and Regeneron Expand Bispecific Cancer Therapy Collaboration with New Targets
CytomX Therapeutics and Regeneron Pharmaceuticals have expanded their ongoing research collaboration focused on developing tumor-activated bispecific cancer therapy candidates, broadening the scope of an agreement that was originally established in 2019. The expanded collaboration introduces additional bispecific targets into...
Business & Industry
Pfizer and Chai Discovery Sign AI Licensing Deal to Accelerate Drug Discovery
Pfizer has entered into a licensing agreement with Chai Discovery, granting the pharmaceutical giant access to Chai's generative AI platform for integration into its drug discovery operations. The deal provides Pfizer with early access to the newly revealed Chai-3...
Business & Industry
Eli Lilly Genetic Medicine Push Expands with Ascidian Deal
Eli Lilly has entered into a research collaboration with Ascidian Therapeutics aimed at discovering and developing treatments for kidney diseases, marking another step in the companyโs ongoing genetic medicineย strategy. The agreement, which could be worth up to $1.9bn for...
Business & Industry
Sanofi and Snowflake Team Up to Deploy AI-Powered Field Agent Support Tool
Sanofi has partnered with cloud data platform company Snowflake to develop an artificial intelligence-driven tool designed to assist the pharmaceutical giant's field sales representatives in their day-to-day operations. The collaboration aims to give Sanofi's field agents faster, more efficient...
Business & Industry
Aragen Backs Renaissance Rare Disease Therapy Launch
Contract research, development, and manufacturing organization (CRDMO) Aragen has announced the successful production of the first commercial-scale GMP batches of Daretabart (hu1418K322A), the lead therapeutic candidate of UK-based Renaissance Pharma Limited. The milestone marks a key step forward in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















